KERLINK (ALKLK.PA) Fundamental Analysis & Valuation

EPA:ALKLK • FR0013156007

Current stock price

0.88 EUR
0 (0%)
Last:

This ALKLK.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALKLK.PA Profitability Analysis

1.1 Basic Checks

  • ALKLK had negative earnings in the past year.
  • ALKLK had a positive operating cash flow in the past year.
  • In the past 5 years ALKLK always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: ALKLK reported negative operating cash flow in multiple years.
ALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFALKLK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • ALKLK has a Return On Assets of -15.54%. This is in the lower half of the industry: ALKLK underperforms 77.42% of its industry peers.
  • ALKLK has a Return On Equity of -101.88%. This is amonst the worse of the industry: ALKLK underperforms 83.87% of its industry peers.
Industry RankSector Rank
ROA -15.54%
ROE -101.88%
ROIC N/A
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ALKLK.PA Yearly ROA, ROE, ROICALKLK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • ALKLK has a Gross Margin of 34.70%. This is in the lower half of the industry: ALKLK underperforms 74.19% of its industry peers.
  • ALKLK's Gross Margin has declined in the last couple of years.
  • ALKLK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
ALKLK.PA Yearly Profit, Operating, Gross MarginsALKLK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1

2. ALKLK.PA Health Analysis

2.1 Basic Checks

  • ALKLK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALKLK has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALKLK has been increased compared to 5 years ago.
  • The debt/assets ratio for ALKLK is higher compared to a year ago.
ALKLK.PA Yearly Shares OutstandingALKLK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALKLK.PA Yearly Total Debt VS Total AssetsALKLK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ALKLK has an Altman-Z score of 0.94. This is a bad value and indicates that ALKLK is not financially healthy and even has some risk of bankruptcy.
  • ALKLK has a worse Altman-Z score (0.94) than 61.29% of its industry peers.
  • ALKLK has a debt to FCF ratio of 33.45. This is a negative value and a sign of low solvency as ALKLK would need 33.45 years to pay back of all of its debts.
  • The Debt to FCF ratio of ALKLK (33.45) is worse than 64.52% of its industry peers.
  • A Debt/Equity ratio of 2.48 is on the high side and indicates that ALKLK has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.48, ALKLK is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF 33.45
Altman-Z 0.94
ROIC/WACCN/A
WACC5.87%
ALKLK.PA Yearly LT Debt VS Equity VS FCFALKLK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that ALKLK should not have too much problems paying its short term obligations.
  • ALKLK has a Current ratio (1.81) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.81 indicates that ALKLK may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.81, ALKLK is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.81
ALKLK.PA Yearly Current Assets VS Current LiabilitesALKLK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. ALKLK.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.30% over the past year.
  • Looking at the last year, ALKLK shows a decrease in Revenue. The Revenue has decreased by -4.86% in the last year.
  • Measured over the past years, ALKLK shows a decrease in Revenue. The Revenue has been decreasing by -2.20% on average per year.
EPS 1Y (TTM)24.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.56%
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%16.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.01% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 22.13% on average over the next years. This is a very strong growth
EPS Next Y50.98%
EPS Next 2Y32.84%
EPS Next 3Y33.01%
EPS Next 5YN/A
Revenue Next Year16.28%
Revenue Next 2Y19.75%
Revenue Next 3Y22.13%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKLK.PA Yearly Revenue VS EstimatesALKLK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
ALKLK.PA Yearly EPS VS EstimatesALKLK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

2

4. ALKLK.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALKLK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALKLK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKLK.PA Price Earnings VS Forward Price EarningsALKLK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ALKLK is valued a bit cheaper than 67.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.35
EV/EBITDA N/A
ALKLK.PA Per share dataALKLK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALKLK's earnings are expected to grow with 33.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.84%
EPS Next 3Y33.01%

0

5. ALKLK.PA Dividend Analysis

5.1 Amount

  • No dividends for ALKLK!.
Industry RankSector Rank
Dividend Yield 0%

ALKLK.PA Fundamentals: All Metrics, Ratios and Statistics

KERLINK

EPA:ALKLK (4/2/2026, 7:00:00 PM)

0.88

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-14
Earnings (Next)04-23
Inst Owners5.89%
Inst Owner ChangeN/A
Ins Owners5.6%
Ins Owner ChangeN/A
Market Cap6.57M
Revenue(TTM)12.68M
Net Income(TTM)-2.97M
Analysts40
Price Target1.12 (27.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF 20.35
P/OCF 4.77
P/B 2.25
P/tB 20.54
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.04
FCFY4.91%
OCF(TTM)0.18
OCFY20.98%
SpS1.7
BVpS0.39
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.54%
ROE -101.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.7%
FCFM 2.55%
ROA(3y)-14.32%
ROA(5y)-15.26%
ROE(3y)-59.86%
ROE(5y)-55.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.77%
GM growth 5Y-8.4%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF 33.45
Debt/EBITDA N/A
Cap/Depr 76.14%
Cap/Sales 8.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.81
Altman-Z 0.94
F-Score6
WACC5.87%
ROIC/WACCN/A
Cap/Depr(3y)95.64%
Cap/Depr(5y)79.23%
Cap/Sales(3y)11.29%
Cap/Sales(5y)9.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.56%
EPS Next Y50.98%
EPS Next 2Y32.84%
EPS Next 3Y33.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y-16.27%
Revenue growth 5Y-2.2%
Sales Q2Q%16.18%
Revenue Next Year16.28%
Revenue Next 2Y19.75%
Revenue Next 3Y22.13%
Revenue Next 5YN/A
EBIT growth 1Y10.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y43.18%
EBIT Next 5YN/A
FCF growth 1Y104.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.67%
OCF growth 3YN/A
OCF growth 5YN/A

KERLINK / ALKLK.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KERLINK?

ChartMill assigns a fundamental rating of 2 / 10 to ALKLK.PA.


Can you provide the valuation status for KERLINK?

ChartMill assigns a valuation rating of 2 / 10 to KERLINK (ALKLK.PA). This can be considered as Overvalued.


How profitable is KERLINK (ALKLK.PA) stock?

KERLINK (ALKLK.PA) has a profitability rating of 1 / 10.


How financially healthy is KERLINK?

The financial health rating of KERLINK (ALKLK.PA) is 1 / 10.